HONG KONG vs Philips North America: FDA Enforcement Comparison

Philips North America has been the subject of 357 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for HONG KONG.

HONG KONG: 0 warning letters, 0 recalls, 1 approval record, 0 Form 483s.

Philips North America: 0 warning letters, 357 recalls, 0 approval records, 0 Form 483s.

Side by side

HONG KONG — Warning letters0

Philips North America — Warning letters0

HONG KONG — Recalls0

Philips North America — Recalls357

HONG KONG — Approval records1

Philips North America — Approval records0

HONG KONG — Form 483s0

Philips North America — Form 483s0

Timeline

HONG KONG

Most recent FDA action: September 25, 2026

Full history →

Philips North America

Most recent FDA action: September 23, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"HONG KONG vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed October 12, 2026. https://argushq.ai/compare/hong-kong-vs-philips-north-america

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗